Metabolic Syndrome in the Mothers of Women with Polycystic Ovarian Syndrome
DOI:
https://doi.org/10.22100/jkh.v6i1.94Keywords:
Metabolic disorders, Polycystic ovarian syndrome, Insulin resistance, Impaired glucose tolerance.Abstract
Introduction: About 40% of PCOS affected women’s sisters have hyperandrogenemia and are exposed to metabolic syndrome risk. This study aimed at investigating metabolic disorders and level of testosterone in immediate relatives (mothers) of patients with polycystic ovarian syndrome.
Methods: The study was conducted over 34 mothers of patients with polycystic ovarian syndrome, and 34 relatives of women without the syndrome. Blood pressure, height and weight, a blood sample were obtained from all participants in order to investigate their serum insulin, blood sugar, testosterone and lipoproteins. Metabolic syndrome was evaluated based on ATPIII (Adult Treatment Panel Ш) and IDF (International Diabetes Federation), and resistance to insulin was evaluated based on HOMA indices (Homeostasis Model Assessment Index) and QUICKI (Quantitative Insulin Sensitivity Check Index) and fasting blood sugar and BMI≤30kg/m2.
Results: The prevalence of metabolic syndrome in mothers of the PCOS was according to ATPIII index and IDF index was not significantly different from the relatives of healthy group (P>0.05). The means of fasting blood sugar, blood pressure, serum testosterone, total cholesterol, LDL. HDL and triglyceride in mothers of the healthy women were very different from those of the mothers of the patients (P<0.05). Central obesity was not significantly different in the two groups (P>0.05).
Conclusion: Immediate relatives especially mothers of women suffering from polycystic ovarian syndrome are exposed to metabolic syndrome.
References
Speroff L, Fritz F. Clinical gynecologic endocrinology and infertility. 7th ed. 2005492-70.
Zawadsky JK, Dunalf A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP. In Current issues in endocrinology and metabolism: polystic ovary syndrome. Blachwell Cambridge;1992:377- 384.
Baillargeon JP. Use of insulin sensitizers in polycystic ovarian syndrome. Curr Opin Investig Drugs 2005;6(10):1012-22.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25.
Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 1993;44:121-31.
Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, etal. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JMA 2002;288(21):2709-16.
De Flines J, Scheen AJ. Management of metabolic syndrome and associated cardiovascular risk factors. Acta Gastroenterol Belg 2010;73(2):261-6.
Pacholczyk M, Ferenc T, Kowalski J. The metabolic syndrome. Part II: its mechanisms of development and its complications. Postepy Hig Med Dosw (Online) 2008;62:543-58.
Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989;149(7):1514-20.
Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, et al. Hyperinsulinemia. A link between hypertension, obesity and glucose intolerance. J Clin Invest 1985;75(3):809-817.
Glueck CJ, Papanna R, Wang P, Goldenberg N, Sieve-Smith L. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism 2003;52(7):908-15.
Nestler JE. Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome and its clinical implications. Semin Reprod Endocrinol 1997;15(2):111-22.
Benitez R, Sir-Petermann T, Palomino A, Angel B, Maliqueo M, Perez F, et al. Prevalence of metabolic disorders among family members of patients with polycystic ovary Syndrome. Rev Med Chil 2001;129(70):707-12.
Yildiz BO, Yarali H, Oguz H, Bayraktar M. Glucose intolerance, insulin resistance and hyperandrogenemia in first degree relatives of woman with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88(5):2031-6.
Reddy KS. Cardiovascular disease in non-western Countries. N Engl J Med 2004;350(24):2438-40.
Sarraf-Zadegan N, Sayed-Tabatabaei FA, Bashardoost N. Maleki A, Totonchi M, Habibi HR, et al. The prevalence of coronary artery disease in an urban population in Isfahan, Iran. Acta Cardiol 1999;54(5):257-63.
Hettihewa LM, Palangasinghe S, Jayasinghe SS, Gunasekara SW, Weerarathna TP. Comparison of insulin resistance by indirect methods-HOMA,QUICKI And McAuley- with fasting insulin in patients with type 2 diabetes in Galle, Sri lanka: A pilot study. OJHAS 2006;5(1):1-8.
Herbicek J, Janout V, Malincikova J, Horakova D, Cizek L. Detection of insulin resistance by simple quatitative insulin sensivity check QUICKI for epidemiological assesment and prevention. J Clin Endocrinol Metab 2002;87(1):144-147.
Barbato K, Vieira Martins R, Rodrigues M, Braga J, Francischetti E, Genelhu V. Effect of greater than 5% weight reduction on hemodynamic metabolic and neuroendocrine profiles of grade I obese subjects. Arq Bras Cardiol 2006;87(1):2006.
Foss-Freitas MC, Foss MC. Comparison of the homeostasis model assessment and quantitative insulin sensitivity check index with data from forearm metabolic studies for the in vivo assessment of insulin sensitivity. Braz J Med Biol Res 2004;37(5):663-8.
Yokoyama H, Emoto M, Fujiwara S, Motoyama K, Morioka T, Komatsu M, et al. Quatitative insulin sensitivity check index and reciprocalindex of Homeostasis model assessment in normal range weight and moderately obese type2 diabetic petients. Diabetese Care 2003;26:2426-2432.22. MCAuley KA, Wiliams Sm, Mann JI, Walker RJ, Lewis-Barned NJ, Temple LA, et al. Diagnosing insulin resistance in the general population. Diabetes Care 2001;24(3):460-464.
Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on Detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). JAMA 2001;285(19):2486-97.
International Diabetes Federation Press Conference: The IDF consensus worldwide definition of the metabolic syndrome [article online], 2005. Available from: URL: http://www .idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf. Accessed 14 April 2005.
Sir-Petermann T, Angel B, Maliqueo M, Carvajal F, Santos JL, Pérez-Bravo F. Prevalence of type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome. Diabetologia 2002;45(7):959-64.
Legro RS, Kunselman AR, Demers L, Wang SC, Bentley-Lewis R, Dunaif A. Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome, J Clin Endocrinol Metab 2002;87(5):2134-8.
Isomaa B. A major health hazard: the metabolic syndrome. Life Sci 2003;73(19):2395-411.
Camacho P, Pitale S, Abraira C. Beneficial and detrimental effects of intensive glycaemic control, with emphasis on type 2 diabetes mellitus. Drug Aging 2000;17(6):463-76.
Coviello AD, Sam S, Legro RS, Dunaif A. High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity. J Clin Endocrinol Metab 2009;94(11):4361-6.
Meis SB, Schuster D, Gaillard T, Osei K. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox. Ethn Dis 2006;16(4):830-6.
Zimmet PZ. Diabetes epidemiology as a tool to trigger diabetes research and care. Diabetologia 1999;42(5):499-518.
Unlühizarci K, Ozocak M, Tanriverdi F, Atmaca H, Keleştimur F. Investigation of hypothalamo-pituitary-gonadal axis and glucose intolerance among the first- degree female relatives of women with polycystic ovary syndrome. Fertil Steril 2007;87(6):1377-1382.
Blaha MJ, Gebretsadik T, Shintani A, Elasy TA. Waist circumference, not the metabolic syndrome, predicts glucose deterioration in type 2 diabetes. Obesity (Silver Spring) 2008;16(4):869-874.
Norman Rj, Masters S, Hague W. Hyperinsulinemia is Common in Family members of women with polcystic ovary syndrome. Fertil Steril 1996;66(6):942-947.
Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997;14(suppl.5):s1-85.
Castelo-Branco C, Steinvarcel F, Osorio A, Ros C, Balasch J. Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism. Gynecol Endocrinol 2010;26(10):736-742.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
